A Study to Assess AMG 701 Montherapy, or in Combination With Pomalidomide, With or Without, Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma

NCT03287908 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

174

Enrollment

INDUSTRY

Sponsor class

Stopped business decision, not safety reasons.

Conditions

Relapsed/Refractory Multiple Myeloma

Interventions

DRUG: AMG 701
DRUG: Pomalidomide
DRUG: Dexamethasone

Sponsor

Amgen